Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raja Atreya

Showing results (21-30 of 295) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|March 5, 2023
The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitisRaja Atreya, Markus F Neurath
Journal of Crohn'S & Colitis|October 21, 2024
IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era?Raja Atreya, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|September 8, 2022
Induction of microRNA-124 as a novel therapeutic concept in ulcerative colitisRaja Atreya, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|September 8, 2023
Further efficacy and safety data for maintenance upadacitinib in ulcerative colitisRaja Atreya, Markus F Neurath
Nature Reviews. Gastroenterology & Hepatology|December 3, 2014
IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBDRaja Atreya, Markus F Neurath
Digestive Diseases (Basel, Switzerland)|June 23, 2016
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel DiseasesRaja Atreya, Markus F Neurath
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2024
Biomarkers for Personalizing IBD Therapy: The Quest ContinuesRaja Atreya, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|January 10, 2025
No easy way out: blocking lymphocyte egress by the S1P1 receptor 1 modulator tamuzimod in ulcerative colitisRaja Atreya, Markus F Neurath
Visceral Medicine|June 15, 2017
Current and Future Targets for Mucosal Healing in Inflammatory Bowel DiseaseRaja Atreya, Markus F Neurath
Cellular and Molecular Gastroenterology and Hepatology|November 6, 2021
Deciphering Novel Mechanistic and Pharmacokinetic Effects of Tofacitinib in Intestinal Inflammation: Expect the UnexpectedRaja Atreya, Markus F Neurath
Pageof 30

Showing results (21-30 of 295) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|March 5, 2023
The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitisRaja Atreya, Markus F Neurath
Journal of Crohn'S & Colitis|October 21, 2024
IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era?Raja Atreya, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|September 8, 2022
Induction of microRNA-124 as a novel therapeutic concept in ulcerative colitisRaja Atreya, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|September 8, 2023
Further efficacy and safety data for maintenance upadacitinib in ulcerative colitisRaja Atreya, Markus F Neurath
Nature Reviews. Gastroenterology & Hepatology|December 3, 2014
IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBDRaja Atreya, Markus F Neurath
Digestive Diseases (Basel, Switzerland)|June 23, 2016
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel DiseasesRaja Atreya, Markus F Neurath
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2024
Biomarkers for Personalizing IBD Therapy: The Quest ContinuesRaja Atreya, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|January 10, 2025
No easy way out: blocking lymphocyte egress by the S1P1 receptor 1 modulator tamuzimod in ulcerative colitisRaja Atreya, Markus F Neurath
Visceral Medicine|June 15, 2017
Current and Future Targets for Mucosal Healing in Inflammatory Bowel DiseaseRaja Atreya, Markus F Neurath
Cellular and Molecular Gastroenterology and Hepatology|November 6, 2021
Deciphering Novel Mechanistic and Pharmacokinetic Effects of Tofacitinib in Intestinal Inflammation: Expect the UnexpectedRaja Atreya, Markus F Neurath
Pageof 30